Certara, Inc. (NASDAQ:CERT) Shares Sold by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund cut its holdings in shares of Certara, Inc. (NASDAQ:CERT) by 9.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 58,305 shares of the company’s stock after selling 6,380 shares during the period. Illinois Municipal Retirement Fund’s holdings in Certara were worth $1,026,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Covestor Ltd lifted its position in Certara by 14,940.0% during the third quarter. Covestor Ltd now owns 3,760 shares of the company’s stock valued at $55,000 after purchasing an additional 3,735 shares during the period. Gamco Investors INC. ET AL acquired a new position in Certara during the third quarter valued at $145,000. NorthRock Partners LLC acquired a new position in Certara during the third quarter valued at $168,000. Natixis Advisors L.P. raised its position in shares of Certara by 13.4% in the third quarter. Natixis Advisors L.P. now owns 15,136 shares of the company’s stock worth $220,000 after acquiring an additional 1,791 shares during the period. Finally, Pacer Advisors Inc. raised its position in shares of Certara by 1,704.0% in the fourth quarter. Pacer Advisors Inc. now owns 12,754 shares of the company’s stock worth $224,000 after acquiring an additional 12,047 shares during the period. 73.96% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Certara

In related news, SVP Richard M. Traynor sold 3,000 shares of the company’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $18.00, for a total transaction of $54,000.00. Following the completion of the sale, the senior vice president now owns 173,524 shares of the company’s stock, valued at approximately $3,123,432. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, SVP Richard M. Traynor sold 6,000 shares of the stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $18.00, for a total value of $108,000.00. Following the completion of the sale, the senior vice president now owns 165,368 shares of the company’s stock, valued at approximately $2,976,624. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Richard M. Traynor sold 3,000 shares of the stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $18.00, for a total transaction of $54,000.00. Following the completion of the sale, the senior vice president now directly owns 173,524 shares of the company’s stock, valued at approximately $3,123,432. The disclosure for this sale can be found here. In the last quarter, insiders sold 23,427 shares of company stock valued at $405,095. Corporate insiders own 2.60% of the company’s stock.

Certara Stock Up 1.7 %

CERT opened at $16.57 on Monday. Certara, Inc. has a twelve month low of $11.81 and a twelve month high of $24.64. The company has a market cap of $2.65 billion, a PE ratio of -47.34, a price-to-earnings-growth ratio of 1.71 and a beta of 1.63. The company has a quick ratio of 2.62, a current ratio of 2.62 and a debt-to-equity ratio of 0.28. The company has a 50-day moving average price of $17.69 and a 200 day moving average price of $16.27.

Certara (NASDAQ:CERT) last announced its quarterly earnings data on Thursday, February 29th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.04). Certara had a negative net margin of 15.62% and a positive return on equity of 4.33%. The business had revenue of $88.01 million for the quarter, compared to analysts’ expectations of $86.80 million. Sell-side analysts expect that Certara, Inc. will post 0.29 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have weighed in on CERT shares. JMP Securities started coverage on shares of Certara in a research report on Thursday, April 4th. They issued a “market perform” rating for the company. Barclays upped their price objective on shares of Certara from $16.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 25th. UBS Group upped their price objective on shares of Certara from $17.00 to $20.00 and gave the stock a “neutral” rating in a research report on Friday, March 1st. KeyCorp upgraded shares of Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 price objective for the company in a research report on Wednesday, April 10th. Finally, Leerink Partnrs reiterated a “market perform” rating on shares of Certara in a research report on Monday, February 26th. Seven investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $20.06.

Certara Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.